Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients
About this study
Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.
- Condition
- Lung Cancer - Non Small Cell, Lung Cancer (NSCLC)
- Tested
- Early palliative care integration, Standard systemic treatment for advanced lung cancer
- Sponsor
- Mahidol University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Study condition: Lung Cancer - Non Small Cell, Lung Cancer (NSCLC)
- Age at least 18 years old
- Pathologically confirmed advanced non-small cell lung cancer
- Plan to receive systemic treatment for lung cancer within three weeks
- ECOG performance status 0-2 with estimated life expectancy \> 24 weeks
- Having at least 4 scores according to Edmonton Symptom Assessment System (ESAS)
- Able to complete the questionnaires
Exclusion 1
- Had received systemic treatment for advanced lung cancer before
Where
1 site, 1 recruiting
Siriraj Hospital
Bangkok, Thailand
Contact
-
Lucksamon Thamlikitkul, MD, PhD
+6624194489 lucksamon.tha@mahidol.edu
Potential match only. Final eligibility is determined by the study team.